Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
24%
OVERLAP
BY WEIGHT
24
# OF OVERLAPPING
HOLDINGS
WELS.DE
86
HOLDINGS
28%
ALSO IN EXV4.DE
EXV4.DE
60
HOLDINGS
53%
ALSO IN WELS.DE
SECTOR DRIFT (WELS.DE minus EXV4.DE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WELS.DE |
Weight in EXV4.DE |
Overlap | |
|---|---|---|---|---|
 |
ROCHE HOLDING AG-BR | 4.6% | 15.1% | 4.6% |
 |
ASTRAZENECA PLC | 4.3% | 13.8% | 4.3% |
|
NOVARTIS AG | 3.8% | 13.7% | 3.8% |
 |
NOVO NORDISK A/S-B | 2.9% | 9.3% | 2.9% |
 |
SANOFI-AVENTIS | 1.4% | 5.2% | 1.4% |
WELS.DE Overweight Relative to EXV4.DE
 |
ELI LILLY & CO | 11.6% |
|
ABBVIE INC | 6.6% |
|
UNITEDHEALTH GROUP INC | 5.4% |
|
MERCK & CO. INC. | 4.1% |
|
THERMO FISHER SCIENTIFIC INC | 3.7% |
|
AMGEN INC | 3.0% |
|
INTUITIVE SURGICAL INC | 2.8% |
|
ABBOTT LABORATORIES | 2.6% |
|
GILEAD SCIENCES INC | 2.5% |
|
DANAHER CORP | 2.2% |
WELS.DE Underweight Relative to EXV4.DE
|
ROCHE HOLDING AG-BR | -10.6% |
|
NOVARTIS AG | -9.8% |
|
ASTRAZENECA PLC | -9.5% |
|
NOVO NORDISK A/S-B | -6.4% |
|
SANOFI-AVENTIS | -3.8% |
|
ESSILOR INTERNATIONAL | -3.7% |
|
GSK PLC | -3.5% |
 |
BAYER AG | -2.4% |
|
HALEON PLC | -2.3% |
|
LONZA GROUP AG-REG | -1.9% |